MEDTRONIC PLC (2M6.DE) Stock Price & Overview

FRA:2M6IE00BTN1Y115

Current stock price

73.88 EUR
-0.62 (-0.83%)
Last:

The current stock price of 2M6.DE is 73.88 EUR. Today 2M6.DE is down by -0.83%. In the past month the price decreased by -3.2%. In the past year, price increased by 1.25%.

2M6.DE Key Statistics

52-Week Range70.61 - 91.5
Current 2M6.DE stock price positioned within its 52-week range.
1-Month Range73.79 - 77.51
Current 2M6.DE stock price positioned within its 1-month range.
Market Cap
94.853B
P/E
15.42
Fwd P/E
14.08
EPS (TTM)
4.79
Dividend Yield
3.23%

2M6.DE Stock Performance

Today
-0.83%
1 Week
-1.30%
1 Month
-3.20%
3 Months
-12.21%
Longer-term
6 Months -9.51%
1 Year +1.25%
2 Years -2.13%
3 Years -10.62%
5 Years -31.47%
10 Years +7.59%

2M6.DE Stock Chart

MEDTRONIC PLC / 2M6 Daily stock chart

2M6.DE Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to 2M6.DE. When comparing the yearly performance of all stocks, 2M6.DE is a bad performer in the overall market: 80.69% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

2M6.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to 2M6.DE. 2M6.DE has an average financial health and profitability rating.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

2M6.DE Earnings

On February 17, 2026 2M6.DE reported an EPS of 1.36 and a revenue of 9.02B. The company beat EPS expectations (0.89% surprise) and beat revenue expectations (0.26% surprise).

Next Earnings DateMay 20, 2026
Last Earnings DateFeb 17, 2026
PeriodQ3 / 2026
EPS Reported$1.36
Revenue Reported9.017B
EPS Surprise 0.89%
Revenue Surprise 0.26%

2M6.DE Forecast & Estimates

37 analysts have analysed 2M6.DE and the average price target is 95.12 EUR. This implies a price increase of 28.74% is expected in the next year compared to the current price of 73.88.

For the next year, analysts expect an EPS growth of 2.83% and a revenue growth 7.95% for 2M6.DE


Analysts
Analysts76.22
Price Target95.12 (28.75%)
EPS Next Y2.83%
Revenue Next Year7.95%

2M6.DE Groups

Sector & Classification

Index Membership

2M6.DE Financial Highlights

Over the last trailing twelve months 2M6.DE reported a non-GAAP Earnings per Share(EPS) of 4.79. The EPS increased by 4.87% compared to the year before.


Income Statements
Revenue(TTM)35.48B
Net Income(TTM)4.61B
Industry RankSector Rank
PM (TTM) 13%
ROA 5.04%
ROE 9.42%
Debt/Equity 0.57
Chartmill High Growth Momentum
EPS Q2Q%-2.16%
Sales Q2Q%8.74%
EPS 1Y (TTM)4.87%
Revenue 1Y (TTM)6.88%

2M6.DE Ownership

Ownership
Inst Owners87.92%
Shares1.28B
Float1.28B
Ins Owners0.28%
Short Float %N/A
Short RatioN/A

About 2M6.DE

Company Profile

2M6 logo image Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. The company is headquartered in Galway, Connacht and currently employs 95,000 full-time employees. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.

Company Info

IPO: 1977-11-21

MEDTRONIC PLC

Building Two Parkmore Business Park West

GALWAY CONNACHT IE

Employees: 95000

2M6 Company Website

2M6 Investor Relations

Phone: 35314381700

MEDTRONIC PLC / 2M6.DE FAQ

What does MEDTRONIC PLC do?

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. The company is headquartered in Galway, Connacht and currently employs 95,000 full-time employees. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.


What is the current price of 2M6 stock?

The current stock price of 2M6.DE is 73.88 EUR. The price decreased by -0.83% in the last trading session.


What is the dividend status of MEDTRONIC PLC?

MEDTRONIC PLC (2M6.DE) has a dividend yield of 3.23%. The yearly dividend amount is currently 2.36.


What is the ChartMill technical and fundamental rating of 2M6 stock?

2M6.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


What is the GICS sector and industry of 2M6 stock?

MEDTRONIC PLC (2M6.DE) operates in the Health Care sector and the Health Care Equipment & Supplies industry.


Should I buy 2M6 stock?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 2M6.DE.


Can you provide the growth outlook for MEDTRONIC PLC?

The Revenue of MEDTRONIC PLC (2M6.DE) is expected to grow by 7.95% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.